The limited amount of data to guide dosing of antiviral therapies for the novel coronavirus stands out in the American Society of Health-System Pharmacists’ assessment of the evidence available for potential COVID-19 treatments.
ASHP created the evidence table to “help practitioners better understand current approaches related to treatment and care,” and noted “the uniqueness of each medical
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?